rs2228078
Variant summary
Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1
The NM_000823.4(GHRHR):āc.1265T>Cā(p.Met422Thr) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0238 in 1,613,800 control chromosomes in the GnomAD database, including 2,066 homozygotes. In-silico tool predicts a benign outcome for this variant. 14/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Benign (ā ā ).
Frequency
Consequence
NM_000823.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -20 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
GHRHR | NM_000823.4 | c.1265T>C | p.Met422Thr | missense_variant | 13/13 | ENST00000326139.7 | NP_000814.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
GHRHR | ENST00000326139.7 | c.1265T>C | p.Met422Thr | missense_variant | 13/13 | 1 | NM_000823.4 | ENSP00000320180 | P1 |
Frequencies
GnomAD3 genomes AF: 0.0289 AC: 4402AN: 152236Hom.: 252 Cov.: 33
GnomAD3 exomes AF: 0.0503 AC: 12634AN: 251138Hom.: 1351 AF XY: 0.0430 AC XY: 5843AN XY: 135788
GnomAD4 exome AF: 0.0232 AC: 33972AN: 1461446Hom.: 1811 Cov.: 31 AF XY: 0.0231 AC XY: 16767AN XY: 727034
GnomAD4 genome AF: 0.0289 AC: 4407AN: 152354Hom.: 255 Cov.: 33 AF XY: 0.0310 AC XY: 2313AN XY: 74502
ClinVar
Submissions by phenotype
not provided Benign:2
Benign, criteria provided, single submitter | clinical testing | GeneDx | Nov 12, 2018 | This variant is associated with the following publications: (PMID: 22449891) - |
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 31, 2024 | - - |
not specified Benign:1
Benign, criteria provided, single submitter | clinical testing | Eurofins Ntd Llc (ga) | Jun 28, 2018 | - - |
Isolated growth hormone deficiency type IB Benign:1
Benign, criteria provided, single submitter | clinical testing | Illumina Laboratory Services, Illumina | Jan 13, 2018 | This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at